No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride levels; PPL Taiwan green propolis; and NBM-BMX, an oral softgel formulation specifically developed for oncology treatment. The company was established in 2000 and maintains its headquarters in Taipei, Taiwan.
www.naturewise.com.twNo one on the platform currently holds 4732.TWO.
No tracked institution reports a position in 4732.TWO as of their last filing.
No one on the platform has traded 4732.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4732.TWONatureWise Biotech & Medicals Corporation | $18.00 | +0.56% | $869M | — |
| 3118.TWOLevel Biotechnology Inc. | $31.40 | -0.79% | $1.0B | — |
| 4188.TWOAmCad BioMed Corporation | $14.15 | -0.35% | $896M | — |
| 4192.TWOSynCore Biotechnology Co.,Ltd | $19.45 | +3.18% | $684M | — |
| 6652.TWOEusol Biotech Co.,Ltd. | $1.96 | +0.00% | $269M | — |
| 6810.TWOBio Preventive Medicine Corp. | $20.85 | +0.24% | $1.0B | — |
| 6814.TWOLukas Biomedical Inc. | $18.30 | +0.00% | $766M | — |
Source: Financial Modeling Prep · peers by sector/industry